HRA000529
Title:
The Mutational landscape of Immunoglobulin D myeloma impacts patient outcomes
Release date:
2020-12-31
Description:
IgD multiple myeloma (MM) is a rare plasma cell dyscrasias with extremely poor prognosis and remains a lethal malignancy; whether there is an IgD isotype-specific genomic signature and, if so, how it differs from non-IgD MM is uncertain. To discover genetic alterations that impact IgD MM patient outcomes, we performed a whole-exome sequencing analysis of 34 patients with IgD MM and 61 non-IgD MM controls, respectively. We observed the diversity of mutational patterns within the IgD MM subgroup. We revealed the specific genetic landscape of IgD MM, identified clinically actionable mutations that may be better stratify IgD patients, and offers insights into new avenues for therapeutic options.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
multiple myeloma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
DAC of Du Lab
Contact person:
Du Juan
Email:
juan_du@live.com
Description:
Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital
Individuals & samples
Submitter:   Qian Maoxiang / mxqian@fudan.edu.cn
Organization:   Fudan University
Submission date:   2020-09-08
Requests:   -